Much progress has been made in the past few decades in understanding the sources,
transport, fate, and biological effects of contaminants of emerging concern (CECs) in aquatic …

Antidepressant (AD) drugs are widely prescribed for the treatment of psychiatric disorders,
including depression and anxiety disorders. The continuous use of ADs causes significant …

The increasing levels and frequencies at which active pharmaceutical ingredients (APIs) are
being detected in the environment are of significant concern, especially considering the …

Fluoxetine is one of the most studied and detected selective serotonin reuptake inhibitors in
the aquatic environment, found at concentrations ranging from ng/L to μg/L. Its presence in …

Pharmaceuticals and personal care products (PPCPs) are found in measureable quantities
within the aquatic environment. Selective serotonin reuptake inhibitor (SSRI) …

Pharmaceutical pollutants are detected in aquatic habitats and wildlife tissues globally. One
widespread contaminant of major concern is the antidepressant fluoxetine, which can affect …

Chemical pollution from pharmaceuticals is increasingly recognized as a major hazard to
the aquatic biota. Among the wide variety of pharmaceuticals, fluoxetine (FLX) is one of the …

Social and mating behavior are fundamental fitness determinants in fish. Although fish are
increasingly exposed to pharmaceutical compounds that may alter expression of such …

Contamination of aquatic habitats with pharmaceuticals is a major environmental concern.
Recent studies have detected pharmaceutical pollutants in a wide array of ecosystems and …

Psychoactive pollutants, such as antidepressants, are increasingly detected in the
environment. Mounting evidence suggests that such pollutants can disrupt the behaviour of …